Jack Henry & Associates heads into its May 5 earnings report with short sellers meaningfully more active than they were a month ago.
The sharpest development in the setup is the pace of short-side accumulation. Short interest has risen 30% over the past month to 7.2% of the free float — a level that, while not extreme in absolute terms, represents a significant build. The weekly jump of 14% is particularly notable: roughly 630,000 shares were added to the short book in the five sessions ending April 30, after a jump of similar magnitude on April 23. That acceleration suggests fresh conviction rather than a slow drift. The ORTEX short score, meanwhile, ticked above 51 on April 23 and has held there, up from around 49 the week before — a modest but consistent move in the bearish direction.
The lending market tells a different story, and it matters. Borrow availability remains ample — the cost to borrow is running at just 0.44%, barely changed on the week despite the short interest build. That keeps squeeze risk firmly off the table. The shorts piling in are doing so cheaply and with plenty of room in the lending pool.
On the fundamental debate, bulls point to a strong Q2 print: GAAP operating income rose 29% year-over-year to $159 million, with margins expanding 430 basis points to 25.7%. Management guided for 6% non-GAAP revenue growth and 8-10% non-GAAP operating income growth for 2026. Bears counter that headline growth leans on one-time deconversion fee revenue, and that stripping those out reveals a more modest underlying trajectory. That debate over revenue quality is likely to be central to how the market reads whatever numbers come through on May 5. Analyst sentiment heading into the print is mixed: DA Davidson cut its target from $216 to $198 just yesterday while keeping its Buy rating, a signal of tempered enthusiasm. The stock trades at $154, a meaningful discount to the Street's average target near $198, but that gap reflects the uncertainty around deconversion fees rather than simple undervaluation.
Options positioning is broadly neutral — the put/call ratio of 1.11 is essentially in line with its 20-day average of 1.13, with a z-score barely below zero. There is no unusual defensive hedging visible. The stock is down 2.5% over the past month, though it has recovered 1.9% this week, broadly in line with peers like FIS and TOST, which gained 1.7% and 2.1% respectively. The earnings print will test whether the revenue growth story can hold up on a fee-adjusted basis — and whether a short book that has grown 30% in a month has read that risk correctly.
See the live data behind this article on ORTEX.
Open JKHY on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
